Stayce is a public health leader with a combination of technical expertise, regulatory and clinical knowledge. She is currently serves as the Vice President of Clinical Affairs at Dexcom. Prior to Dexcom, Stayce served as Director of Personalized Medicine/Deputy Office Director of Personalized Med. and Molecular Genetics at FDA. She is internationally recognized for developing critical partnerships with patients, academic investigators, advocacy organizations and medical device manufacturers, and leveraging those relationships to solve the regulatory challenges facing medical devices, with a combination of technical expertise, regulatory and clinical knowledge.